Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer

CONCLUSIONS: We constructed a risk model based on 6 KRAS-associated metabolic genes, which predicted patients' survival with high accuracy and reflected tumor metabolic characteristics and gemcitabine-associated chemoresistance in PC.PMID:34660806 | PMC:PMC8516536 | DOI:10.1155/2021/9949272

Source: Biomed Res - October 18, 2021 Category: Research Authors: Zuyi Ma Zhenchong Li Zuguang Ma Zixuan Zhou Hongkai Zhuang Chunsheng Liu Bowen Huang Yiping Zou Zehao Zheng LinLing Yang Yuanfeng Gong Shanzhou Huang Qi Zhou Chuanzhao Zhang Baohua Hou Source Type: research